CIDP (chronic inflammatory demyelinating polyneuropathy) trials in Brazil
6 of 6 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
- Where
- Brasília, Porto Alegre, Ribeirão Preto, Rio de Janeiro, Salvador, São Paulo
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- argenx
See details and how to joinNCT07091630 · EU 2025-520805-10-00 - Phase 3Taking peopleA Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
- Where
- Salvador, São Paulo
- Age
- 18 years and over
- People
- 218 worldwide
- Run by
- argenx
See details and how to joinNCT06920004 · EU 2024-520097-36-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
- Where
- Belo Horizonte, Campinas, Natal, Porto Alegre, Rio de Janeiro, Salvador, São Paulo
- Age
- 18 years to 75 years
- People
- 256 worldwide
- Run by
- Dianthus Therapeutics
See details and how to joinNCT06858579 - Phase 3Enrolling by invitationLong-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
- Where
- Brasília, Ribeirão Preto, São Paulo
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Sanofi
See details and how to joinNCT06859099 · EU 2024-517032-22-00 - Phase 3Taking peopleA Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Where
- Belo Horizonte, Brasília, Campo Grande, Curitiba, Porto Alegre, São Paulo
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- Sanofi
See details and how to joinNCT06290141 · EU 2023-508338-33-00 - Phase 2Taking peopleImeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Where
- Belo Horizonte, Brasília, Campinas, Curitiba, Joinville, Porto Alegre, Vila Clementino
- Age
- 18 years and over
- People
- 162 worldwide
- Run by
- Immunovant Sciences GmbH
See details and how to joinNCT07032662 · EU 2024-517614-14-00